A1 Refereed original research article in a scientific journal
Thrombotic microangiopathy associated with bortezomib treatment in a patient with relapsed multiple myeloma
Authors: Urpu Salmenniemi, Kari Remes
Publication year: 2012
Journal: Hematology Reports
Article number: e13
Number in series: 2
Volume: 4
Issue: 2
First page : e13
ISSN: 2038-8330
eISSN: 2038-8330
Abstract
Thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated with bortezomib treatment.
Thrombotic thrombocytopenic purpura (TTP) and hemolytic-uremic syndrome (HUS) describe microvascular occlusive disorders characterized by thrombocytopenia due to increased platelet aggregation and fragmentation hemolysis. We report here what to our knowledge is the second case of TTP/HUS associated with bortezomib treatment.
Downloadable publication This is an electronic reprint of the original article. |